NCT02554240View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

December 23, 2014

Primary Completion Date

June 29, 2016

Study Completion Date

October 14, 2016

Conditions
Osteoarthritis, Knee
Interventions
DRUG

DA-5202 20mg

once a week, intra-articular injection, for 3 weeks

DRUG

DA-5202 10mg

once a week, intra-articular injection, for 3 weeks

DRUG

Na Hyaluronate 20mg

once a week, intra-articular injection, for 3 weeks

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02554240 - Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter